The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCES INC | COM | 00032Q104 | 3,735,792 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 2,704,680 | 132,000 | SH | SOLE | 132,000 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 4,555,346 | 76,100 | SH | SOLE | 76,100 | 0 | 0 | ||
APPLIED THERAPEUTICS INC | COM | 03828A101 | 1,759,085 | 525,100 | SH | SOLE | 525,100 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | 4,273,500 | 77,000 | SH | SOLE | 77,000 | 0 | 0 | ||
ARGENX SE - ADR | SPONSORED ADR | 04016X101 | 913,032 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 2,752,404 | 69,400 | SH | SOLE | 69,400 | 0 | 0 | ||
CELLECTAR BIOSCIENCES INC | COM NEW | 15117F807 | 1,322,675 | 477,500 | SH | SOLE | 477,500 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 303,578 | 38,138 | SH | SOLE | 38,138 | 0 | 0 | ||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 3,113,250 | 87,500 | SH | SOLE | 87,500 | 0 | 0 | ||
CYMABAY THERAPEUTICS INC | COM | 23257D103 | 11,624,701 | 492,155 | SH | SOLE | 492,155 | 0 | 0 | ||
DISC MEDICINE INC | COM | 254604101 | 6,671,280 | 115,500 | SH | SOLE | 115,500 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 1,966,219 | 147,836 | SH | SOLE | 147,836 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 1,714,444 | 123,876 | SH | SOLE | 123,876 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 9,824,708 | 425,128 | SH | SOLE | 425,128 | 0 | 0 | ||
4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 1,509,370 | 74,500 | SH | SOLE | 74,500 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 5,209,830 | 324,600 | SH | SOLE | 324,600 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 5,034,072 | 119,489 | SH | SOLE | 119,489 | 0 | 0 | ||
INSMED INC | COM PAR $.01 | 457669307 | 914,205 | 29,500 | SH | SOLE | 29,500 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 10,085,399 | 701,349 | SH | SOLE | 701,349 | 0 | 0 | ||
LEAP THERAPEUTICS INC | COM NEW | 52187K200 | 1,468,018 | 354,166 | SH | SOLE | 354,166 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 5,493,760 | 2,368,000 | SH | SOLE | 2,368,000 | 0 | 0 | ||
NUVATION BIO | *W EXP 07/07/2027 | 67080N119 | 5,450 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
OCULAR THERAPEUTIX INC | COM | 67576A100 | 5,842,600 | 1,310,000 | SH | SOLE | 1,310,000 | 0 | 0 | ||
PRAXIS PRECISION MEDICINES I | COM | 74006W207 | 6,675,890 | 299,636 | SH | SOLE | 299,636 | 0 | 0 | ||
RAYZEBIO INC | COM | 75525N107 | 23,504,550 | 378,069 | SH | SOLE | 378,069 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 4,588,800 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 10,969,470 | 366,015 | SH | SOLE | 366,015 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 6,807,958 | 70,600 | SH | SOLE | 70,600 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 365,000 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 6,353,119 | 3,589,333 | SH | SOLE | 3,589,333 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 3,603,637 | 555,260 | SH | SOLE | 555,260 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 122,808 | 8,867 | SH | SOLE | 8,867 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 7,371,024 | 117,373 | SH | SOLE | 117,373 | 0 | 0 | ||
VERASTEM INC | COM NEW | 92337C203 | 1,890,507 | 232,249 | SH | SOLE | 232,249 | 0 | 0 | ||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 377,720 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 6,131,070 | 281,500 | SH | SOLE | 281,500 | 0 | 0 | ||
ANAVEX LIFE SCIENCES CORP | COM NEW | 032797300 | 22,500 | 1,000 | SH | Put | SOLE | 1,000 | 0 | 0 | |
TOURMALINE BIO INC. | COM | 89157D105 | 6,070,671 | 231,882 | SH | SOLE | 231,882 | 0 | 0 |